Importance of 14-3-3eta, anti-CarP, and anti-Sa in the diagnosis of seronegative rheumatoid arthritis

Key Findings & Data:The study aimed toassess serum 14-3-3eta, anti-CarP, and anti-Sa in seronegative RA (SNRA) patients who were treatment-naïve as well as in healthysubjects.

💡

Conclusion & Impact:Data were analyzed with Mann–Whitney U tests; the P-value was

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Background/aim: Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation. The study aimed toassess serum 14-3-3eta, anti-CarP, and anti-Sa in seronegative RA (SNRA) patients who were treatment-naïve as well as in healthysubjects. This is the first study in the literature to examine these autoantibodies together in SNRA patients.Materials and methods: Forty-five treatment-naïve SNRA patients and 45 healthy subjects were recruited. Drugs change the levels ofautoantibodies; therefore, patients who took any medication had been excluded from our study. Anti-carbamylated protein, anti-Sa, and14-3-3eta were measured by using three different ELISA kits.Results: Median serum concentration of healthy controls in 14-3-3eta was 0.02 (0.02–0.27) ng/mL. Median serum concentration ofSNRA patients in 14-3-3eta was 1.00 (0.48–1.28) ng/mL. Data were analyzed with Mann–Whitney U tests; the P-value was

🔖

Cite This Article

YAMAN, A., ÇETİNER, S., KİBAR, F., SERTDEMİR, Y., SALMAN, R. B., SALMAN, E., BADAK, S. Ö., ERSÖZLÜ, E. D., DURAN, A. Ç., BORAL, B., ERKEN, E. (2022). Importance of 14-3-3eta, anti-CarP, and anti-Sa in the diagnosis of seronegative rheumatoid arthritis. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 5, 1498–1502. https://ajindex.com/articles/610088

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (11)

Somers K, Geusens P, Elewaut D, De Keyser F, Rummens JL et al. Novel autoantibody markers for early and seronegative rheumatoid arthritis. Journal of Autoimmunity 2011
36(1): 33-46. doi: 10.1016/j.jaut.2010.10.003 2. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 1988
31(3): 315-324. 3. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Annals of the Rheumatic Diseases 2010
69(9): 1580-1588. doi: 10.1136/ard.2010.138461 4. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Annals of the Rheumatic Diseases 2006
65(7): 845-851. doi: 10.1136/ ard.2006.051391 5. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Annals of Internal Medicine 2007
146(11): 797-808. 6. Burr ML, Viatte S, Bukhari M, Plant D, Symmons DP et al. Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis. Arthritis Research and Therapy 2012
14(3): R109. doi: 10.1186/ar3834 7. de Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH. Predicting arthritis outcomes: what can be learned from the Leiden Early Arthritis Clinic? Rheumatology 2011
50(1): 93-100. doi: 10.1093/rheumatology/keq230 8. Maksymowych WP, van der Heijde D, Allaart CF, Landewe R, Boire G et al. 14-3-3eta is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage. Arthritis Research & Therapy 2014
16(2): R99. doi: 10.1186/ ar4547. 9. Mydel P, Wang Z, Brisslert M, Hellvard A, Dahlberg LE et al. Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. The Journal of Immunology 2010
184(12): 6882-6890. doi: 10.4049/jimmunol.1000075 10. Vossenaar ER, Deprés N, Lora M, van der Heijden A, Lapointe E et al. The rheumatoid arthritis specific Sa antigen is citrullinated vimentin. Arthritis Research & Therapy 2004
6(2): 142-150. doi: 10.1186/ar1149 11. Aletaha D, Neogi T, Silman AJ, Funovits J, Fel